Florence Coussy

5PUBLICATIONS
27CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 29, 2026
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

|May 29, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum

|Feb 24, 2020
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.

F Coussy, R El Botty, M Lavigne

|Feb 21, 2020
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

Florence Coussy, Rania El-Botty, Sophie Château-Joubert

|Mar 13, 2019
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.

Florence Coussy, Leanne de Koning, Marion Lavigne

Pageof 1

Frequent Collaborators

2 joint publications

Elise Dumas

2 joint publications

Anne-Sophie Hamy

2 joint publications

Kevin Bihan

2 joint publications

Paul Gougis